Benign Blood Diseases

The world-renowned experts at the OSUCCC – James are transforming the way blood diseases are prevented, detected and treated.

Benign blood diseases are not cancerous; however, they are complex, and each patient’s disease is different, behaving differently in the bodies they’re in and calling for a tailored, individualized treatment plan for each patient.

To deliver the most effective treatments, our experts identify and understand benign blood disorders at the biologic and genetic levels, unlocking the molecular code of a patient’s illness and pinpointing what makes each disease grow — then discovering what stops it.

Our team of benign hematology subspecialists spans a broad range of medical disciplines, including hematologists, pharmacists, radiologists and more — all specializing in benign blood disorder research, prevention, detection and treatment.

It’s that subspecialization and singular focus that enable us to discover, develop and deliver the most targeted therapies for each individual patient.

And that means our collective expertise leads to improving outcomes, faster responses, fewer side effects and more hope for patients everywhere.


Hemophilia is a rare, inherited blood disorder that prevents blood from clotting normally. It is not cancerous, but it does cause cuts, no matter how small, or other wounds (including injuries that cause internal bleeding) to require urgent treatment to clot the blood. Our team of experts analyzes the genetic composition of each individual’s type of hemophilia to determine the best possible treatment, offering improved outcomes, faster responses and fewer side effects.

Read More

Sickle Cell Anemia

Sickle cell anemia is a benign (non-cancerous) blood disease where an abnormal hemoglobin is produced that causes cells to change from a round shape to that of a sickle or a crescent. The nationally recognized experts at the OSUCCC – James are at the forefront of delivering the latest, most effective treatments available to develop the very best hemophilia treatments and programs.

Read More

Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura (TTP) is a rare blood disorder that causes clots to form in small blood vessels, which can block the flow of blood and oxygen to organs. At the OSUCCC – James, expert researchers continually focus on studying TPP. In fact, the OSUCCC – James is consistently paving the way in leading-edge therapies and discoveries, leading to even more highly targeted TTP care and treatment.

Read More

Von Willebrand Disease

Von Willebrand disease, or VWD, is an inherited bleeding disorder that slows or prevents the blood’s ability to clot. This can cause abnormal, heavier bleeding after an injury. The OSUCCC – James specialists are world-renowned diagnostic experts and use most advanced diagnostic techniques to detect von Willebrand disease as early as possible, and patients are experiencing improved outcomes, faster responses to treatment and fewer side effects.

Read More